Market Indices
Sector Heatmap
LABT — Lakewood-Amedex Biotherapeutics Inc. Common Stock
NasdaqLakewood-Amedex Biotherapeutics Inc. Common Stock
- O
- 0.88
- H
- 0.89
- L
- 0.82
- V
- 253.7K
LABT — Latest News & Headlines
14 StoriesLakewood-Amedex Biotherapeutics Inc. - Common Stock (Nasdaq:LABT) Stock Quote - FinancialContent
Lakewood-Amedex Biotherapeutics Inc. - Common Stock (Nasdaq:LABT) Stock Quote FinancialContent
LABT Stock Slides As Volatility Spikes On Heavy Trading - StocksToTrade
LABT Stock Slides As Volatility Spikes On Heavy Trading StocksToTrade
LABT Stock Whipsaws As Traders Focus On Cash And Volatility - timothysykes.com
LABT Stock Whipsaws As Traders Focus On Cash And Volatility timothysykes.com
A topical candidate showed lab activity against drug-resistant bacteria from foot ulcers - stocktitan.net
A topical candidate showed lab activity against drug-resistant bacteria from foot ulcers stocktitan.net
These stocks are moving in today's pre-market session - ChartMill
These stocks are moving in today's pre-market session ChartMill
Lakewood-Amedex Reports Positive Nu-3 MIC Data Against Diabetic Foot Ulcer Clinical Isolates - Yahoo Finance
Lakewood-Amedex Reports Positive Nu-3 MIC Data Against Diabetic Foot Ulcer Clinical Isolates Yahoo Finance
Lakewood-Amedex Biotherapeutics (LABT) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat
Lakewood-Amedex Biotherapeutics (LABT) FDA Approvals, PDUFA Dates & Drug Alerts 2026 MarketBeat
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session Benzinga
The first patient has received a germ-fighting gel being tested for infected diabetic foot ulcers. - stocktitan.net
The first patient has received a germ-fighting gel being tested for infected diabetic foot ulcers. stocktitan.net
How Is Lakewood-Amedex (NASDAQ:LABT) Preparing Its Nu-3 Program for Midstage Testing? - Kalkine Media
How Is Lakewood-Amedex (NASDAQ:LABT) Preparing Its Nu-3 Program for Midstage Testing? Kalkine Media
Lakewood-Amedex Biotherapeutics Inc. SEC Filing (Sep 25, 2026) - stocktitan.net
Lakewood-Amedex Biotherapeutics Inc. SEC Filing (Sep 25, 2026) stocktitan.net
Lakewood-Amedex reports positive test data for Nu-3 antimicrobial By Investing.com - Investing.com UK
Lakewood-Amedex reports positive test data for Nu-3 antimicrobial By Investing.com Investing.com UK
Why Is Penny Stock Lakewood-Amedex Biotherapeutics (LABT) Up 20% Today? - TipRanks
Why Is Penny Stock Lakewood-Amedex Biotherapeutics (LABT) Up 20% Today? TipRanks
Beyond Antibiotics: Lakewood-Amedex Advances Diabetic Foot Ulcer Trial - AOL.ca
Beyond Antibiotics: Lakewood-Amedex Advances Diabetic Foot Ulcer Trial AOL.ca